AtriCure (ATRC) Leases (2016 - 2025)
AtriCure (ATRC) has disclosed Leases for 12 consecutive years, with $4.8 million as the latest value for Q4 2025.
- On a quarterly basis, Leases fell 67.2% to $4.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 million, a 67.2% decrease, with the full-year FY2025 number at $4.8 million, down 67.2% from a year prior.
- Leases was $4.8 million for Q4 2025 at AtriCure, down from $6.8 million in the prior quarter.
- In the past five years, Leases ranged from a high of $14.8 million in Q4 2024 to a low of $1.6 million in Q1 2021.
- A 5-year average of $6.8 million and a median of $5.1 million in 2025 define the central range for Leases.
- Biggest YoY gain for Leases was 251.63% in 2025; the steepest drop was 67.2% in 2025.
- AtriCure's Leases stood at $14.6 million in 2021, then crashed by 48.41% to $7.5 million in 2022, then crashed by 42.62% to $4.3 million in 2023, then soared by 241.47% to $14.8 million in 2024, then crashed by 67.2% to $4.8 million in 2025.
- Per Business Quant, the three most recent readings for ATRC's Leases are $4.8 million (Q4 2025), $6.8 million (Q3 2025), and $5.4 million (Q2 2025).